Invention Grant
- Patent Title: Amidated insulin glargine
- Patent Title (中): 酰化甘精胰岛素
-
Application No.: US12349864Application Date: 2009-01-07
-
Publication No.: US08048854B2Publication Date: 2011-11-01
- Inventor: Paul Habermann , Frank Zocher
- Applicant: Paul Habermann , Frank Zocher
- Applicant Address: DE Frankfurt am Main
- Assignee: Sanofi-Aventis Deutschland GmbH
- Current Assignee: Sanofi-Aventis Deutschland GmbH
- Current Assignee Address: DE Frankfurt am Main
- Agency: Scully, Scott, Murphy & Presser, P.C.
- Priority: DE102006031962 20060711
- Main IPC: A61K38/28
- IPC: A61K38/28 ; C07K14/62
Abstract:
The invention relates to insulin glargine which is modified by amidation, especially Gly(A21), Arg(B31), Arg amide (B32) human insulin (insulin glargine amide).
Public/Granted literature
- US20090176692A1 AMIDATED INSULIN GLARGINE Public/Granted day:2009-07-09
Information query
IPC分类:
